Cargando…
Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals
Mupirocin is one of the most effective topically used antibiotic for the treatment of dermatitis, nasal carriage, decolonization of methicillin susceptible Staphylococcus aureus and eradication of methicillin resistant Staphylococcus aureus. Extensive use of this antibiotic has resulted in mupirocin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287686/ https://www.ncbi.nlm.nih.gov/pubmed/37349503 http://dx.doi.org/10.1038/s41598-023-37399-0 |
_version_ | 1785061925590138880 |
---|---|
author | Prakash, Rajni Garg, Amar Arya, Riteshkumar Kumawat, R. K. |
author_facet | Prakash, Rajni Garg, Amar Arya, Riteshkumar Kumawat, R. K. |
author_sort | Prakash, Rajni |
collection | PubMed |
description | Mupirocin is one of the most effective topically used antibiotic for the treatment of dermatitis, nasal carriage, decolonization of methicillin susceptible Staphylococcus aureus and eradication of methicillin resistant Staphylococcus aureus. Extensive use of this antibiotic has resulted in mupirocin resistance in Staphylococcus aureus which is a matter of concern. This study was conducted to evaluate the high and low level of mupirocin resistance in Staphylococcus aureus collected from various Indian hospitals. A total of 600 samples, of which 436 were pus specimens and 164 wound site swabs were collected from 30 Indian hospitals. Disc diffusion and agar dilution methods were used to test mupirocin susceptibility in methicillin resistant Staphylococcus aureus. Out of 600 Staphylococcus aureus isolates, 176 isolates (29.33%) were found to be methicillin resistant Staphylococcus aureus (MRSA). Out of 176 non-duplicate MRSA strains, 138 isolates were found to be mupirocin sensitive, 21 isolates had high level resistance whereas 17 isolates had low level resistance to mupirocin, which contributed 78.41%, 11.93% and 9.66% respectively. Multidrug resistant susceptibility was tested for all the MRSA with Cefuroxime, Cotrimoxazole and Vancomycin antibiotics. All the high and low level resistant strain were subjected to genome screening for mupA ileS gene respectively. mupA gene was found positive in all the high level resistant strain and out of 17 low level resistant strain, 16 strain were found point mutation in V588F of ileS gene. Overall, high rate of mupirocin resistance was found in the studied samples which might be a result of indiscriminate use of mupirocin in the population of studied region. This data emphasizes the urgent need for formulation of a well-defined and regulated guidelines for mupirocin use. Moreover, continuous surveillance is needed for the use of mupirocin and routine test should be performed to detect MRSA in patients and health care personnel to prevent MRSA infections. |
format | Online Article Text |
id | pubmed-10287686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102876862023-06-24 Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals Prakash, Rajni Garg, Amar Arya, Riteshkumar Kumawat, R. K. Sci Rep Article Mupirocin is one of the most effective topically used antibiotic for the treatment of dermatitis, nasal carriage, decolonization of methicillin susceptible Staphylococcus aureus and eradication of methicillin resistant Staphylococcus aureus. Extensive use of this antibiotic has resulted in mupirocin resistance in Staphylococcus aureus which is a matter of concern. This study was conducted to evaluate the high and low level of mupirocin resistance in Staphylococcus aureus collected from various Indian hospitals. A total of 600 samples, of which 436 were pus specimens and 164 wound site swabs were collected from 30 Indian hospitals. Disc diffusion and agar dilution methods were used to test mupirocin susceptibility in methicillin resistant Staphylococcus aureus. Out of 600 Staphylococcus aureus isolates, 176 isolates (29.33%) were found to be methicillin resistant Staphylococcus aureus (MRSA). Out of 176 non-duplicate MRSA strains, 138 isolates were found to be mupirocin sensitive, 21 isolates had high level resistance whereas 17 isolates had low level resistance to mupirocin, which contributed 78.41%, 11.93% and 9.66% respectively. Multidrug resistant susceptibility was tested for all the MRSA with Cefuroxime, Cotrimoxazole and Vancomycin antibiotics. All the high and low level resistant strain were subjected to genome screening for mupA ileS gene respectively. mupA gene was found positive in all the high level resistant strain and out of 17 low level resistant strain, 16 strain were found point mutation in V588F of ileS gene. Overall, high rate of mupirocin resistance was found in the studied samples which might be a result of indiscriminate use of mupirocin in the population of studied region. This data emphasizes the urgent need for formulation of a well-defined and regulated guidelines for mupirocin use. Moreover, continuous surveillance is needed for the use of mupirocin and routine test should be performed to detect MRSA in patients and health care personnel to prevent MRSA infections. Nature Publishing Group UK 2023-06-22 /pmc/articles/PMC10287686/ /pubmed/37349503 http://dx.doi.org/10.1038/s41598-023-37399-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Prakash, Rajni Garg, Amar Arya, Riteshkumar Kumawat, R. K. Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals |
title | Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals |
title_full | Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals |
title_fullStr | Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals |
title_full_unstemmed | Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals |
title_short | Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals |
title_sort | chronicity of high and low level mupirocin resistance in staphylococcus aureus from 30 indian hospitals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287686/ https://www.ncbi.nlm.nih.gov/pubmed/37349503 http://dx.doi.org/10.1038/s41598-023-37399-0 |
work_keys_str_mv | AT prakashrajni chronicityofhighandlowlevelmupirocinresistanceinstaphylococcusaureusfrom30indianhospitals AT gargamar chronicityofhighandlowlevelmupirocinresistanceinstaphylococcusaureusfrom30indianhospitals AT aryariteshkumar chronicityofhighandlowlevelmupirocinresistanceinstaphylococcusaureusfrom30indianhospitals AT kumawatrk chronicityofhighandlowlevelmupirocinresistanceinstaphylococcusaureusfrom30indianhospitals |